About This Event
Acadia Pharmaceuticals (Nasdaq: ACAD), a biopharma company transforming scientific promise into life-changing innovations that advance care for underserved neurological and rare diseases, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Catherine Owen Adams, CEO, rings the Opening Bell.